Washington: US President Donald Trump has raised hopes again by stating that the FDA could approve a vaccine against COVID-19 within 3 to 4 weeks. “The previous administration would have...
New Delhi: A sero survey carried by the Delhi government showed that 79 of 257 people, who had coronavirus, did not have antibodies in them after a few months. However,...
Bhubaneswar: The state government on Tuesday directed the authorities of the districts to manage critical COVID-19 patients in the intensive care unit (ICU) or high dependency unit (HDU) initially instead...
Bhubaneswar: As many as 3714 COVID-19 patients recovered from the disease and were being discharged from different hospitals in the state on Tuesday. Of the new recovered cases, 744 were...
New Delhi: Hyderabad-based Aurobindo Pharma will collaborate with the Biotechnology Industry Research Assistance Council (BIRAC), set up by the Department of Biotechnology for the development of the COVID-19 vaccine, it...
Adding an anti-inflammatory medicine to a drug already widely used for hospitalised COVID-19 patients shortens their recovery time by an additional day, said the drug company Eli Lilly on Monday....
Bhubaneswar: The surge in local contact cases continued in the Odisha capital on Tuesday as the city added 342 new COVID-19 cases to its affected tally, taking it to 16933....
Bhubaneswar: Odisha has conducted 2459000 COVID-19 tests between July 1 and September 15 and the positivity rate is 6.2 per cent. "This is less than the national average of 8.4...
Washington: Microsoft co-founder Bill Gates on Tuesday said that India is a leading vaccine producer and may release huge volumes of COVID-19 vaccine by 2021. According to a PTI report,...
New Delhi/Beijing: Under the garb of China's ambitious Belt and Road Initiative (BRI), China’s Wuhan Institute of Virology and Pakistan Army’s Defence Science and Technology Organisation are allegedly conducting experiments...